Reading time: 8 minutes Charles Okila, MPH Introduction Picture this: a small sample from your routine blood test can be used to check several cancers at a glance. Rather than taking several samples from different individual cancers, a single test is sufficient to identify molecular cues indicating diagnostic problems. This is the emerging promise of... Continue Reading →
How AI Is Changing Access to Cancer Clinical Trials
Reading time: 5 minutes Charles Okila, MPH Clinical trials provide an avenue for many patients suffering from cancer to obtain access to new therapies and more intensive care. However, only a small percentage of cancer patients participate in these clinical trials. The lack of participation is seldom a matter of unwillingness. Instead, it is the... Continue Reading →
